Literature DB >> 11350116

A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

F Watt1, A Martorana, D E Brookes, T Ho, E Kingsley, D S O'Keefe, P J Russell, W D Heston, P L Molloy.   

Abstract

Prostate-specific membrane antigen (PSMA) is an integral membrane protein that is highly expressed on the surface of prostate epithelial cells. It is also expressed on the vascular endothelium of a number of tumor types. We have used an enhancer trap approach with randomly cleaved overlapping DNA fragments from an approximately 55-kb P1 cosmid insert encompassing the 5' half and upstream sequences of the PSMA gene (FOLH1) to isolate an enhancer that strongly activates the FOLH1 core promoter region. The enhancer (PSME) is located in the third intron about 12 kb downstream from the start site of transcription and is characterized by a 72-bp direct repeat within a 331-bp core region. The PSME activates transcription from its own and heterologous promoters in prostate cell lines; enhancement is greatest in the PSMA-expressing cell line LNCaP (>250-fold). The PSME shows essentially no activity in five nonprostate cell lines. PSME-enhanced expression is repressed in the presence of androgen, mimicking the repression of the endogenous FOLH1 gene. The data demonstrate that both cell-type specificity and androgen regulation are intrinsic properties of the enhancer. These properties make the PSME an excellent candidate for regulation of gene expression in gene therapy approaches to prostate cancer. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350116     DOI: 10.1006/geno.2000.6446

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.

Authors:  Makoto Sato; Mai Johnson; Liqun Zhang; Baohui Zhang; Kim Le; Sanjiv S Gambhir; Michael Carey; Lily Wu
Journal:  Mol Ther       Date:  2003-11       Impact factor: 11.454

Review 2.  Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges.

Authors:  Martin K Bakht; So Won Oh; Hyewon Youn; Gi Jeong Cheon; Cheol Kwak; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2016-08-06

3.  Distinct regulatory elements mediate the dynamic expression pattern of Nkx3.1.

Authors:  Hui Chen; Laura N Mutton; Gail S Prins; Charles J Bieberich
Journal:  Dev Dyn       Date:  2005-12       Impact factor: 3.780

Review 4.  A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies.

Authors:  Denise S O'Keefe; Dean J Bacich; Steve S Huang; Warren D W Heston
Journal:  J Nucl Med       Date:  2018-04-19       Impact factor: 10.057

Review 5.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

6.  Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.

Authors:  Mikhail G Dozmorov; Robert E Hurst; Daniel J Culkin; Bradley P Kropp; Mark Barton Frank; Jeanette Osban; Trevor M Penning; Hsueh-Kung Lin
Journal:  Prostate       Date:  2009-07-01       Impact factor: 4.104

7.  Promoter analysis of human glutamate carboxypeptidase II.

Authors:  Liqun Han; Dona Lee Wong; Guochuan Tsai; Zhichun Jiang; Joseph T Coyle
Journal:  Brain Res       Date:  2007-07-17       Impact factor: 3.252

8.  Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines.

Authors:  D S Cross; J K Burmester
Journal:  Med Oncol       Date:  2007-06-27       Impact factor: 3.064

Review 9.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

Review 10.  More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond.

Authors:  Anniina Hyväkkä; Verneri Virtanen; Jukka Kemppainen; Tove J Grönroos; Heikki Minn; Maria Sundvall
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.